Anthem Blue Cross and Blue Shield | CommercialOctober 1, 2021
Specialty pharmacy updates are available
Specialty pharmacy updates for Anthem Blue Cross and Blue Shield (Anthem) are listed below.
For Anthem along with our affiliate HealthKeepers, Inc., prior authorization clinical review of these specialty pharmacy drugs will be managed by Anthem. Drugs used for the treatment of Oncology will still require pre-service clinical review by AIM Specialty Health® (AIM), a separate company.
This applies to members with Preferred Provider Organization (PPO), HealthKeepers (HMO), POS AdvantageOne, and Act Wise (CDH plans).
Please note that inclusion of National Drug Code (NDC) code on your claim will help expedite claim processing of drugs billed with a Not Otherwise Classified (NOC) code.
The Health Plan requires that claims for injection services performed in the office setting must include the applicable HCPCS J-code, Q-code, or S-code, with the corresponding National Drug Code, for the injected substance. This requirement is consistent with the Centers for Medicare & Medicaid Services (CMS) guidelines. A covered drug will not be eligible for reimbursement when the NDC is not reported on the same claim.
Site of care updates
Effective for dates of service on and after January 1, 2022, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our site of care review process.
Access our Clinical Criteria to view the complete information for these site of care updates.
Clinical Criteria |
HCPCS or CPT Code(s) |
Drug |
*ING-CC-0062 |
Q5121 |
Avsola |
*ING-CC-0081 |
J0584 |
Crysvita |
*ING-CC-0162 |
J3241 |
Tepezza |
* Non-oncology use is managed by the medical specialty drug review team.
Quantity limit updates
Effective for dates of service on and after January 1, 2022, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our quantity limit review process.
Access our Clinical Criteria to view the complete information for these quantity limit updates.
Clinical Criteria |
Drug |
HCPCS or CPT Code(s) |
ING-CC-0009 |
Lemtrada |
J0202 |
ING-CC-0011 |
Ocrevus |
J2350 |
ING-CC-0014 |
Avonex |
J1826 |
Q3027 |
||
Betaseron |
J1830 |
|
Copaxone |
J1595 |
|
Extavia |
J1830 |
|
Glatopa |
J1595 |
|
Plegridy |
J3590 |
|
C9399 |
||
Rebif |
J1826 |
|
Q3028 |
||
ING-CC-0020 |
Tysabri |
J2323 |
ING-CC-0029 |
Dupixent |
J3490 |
J3590 |
||
ING-CC-0038 |
Bonsity |
J3110 |
Forteo |
J3110 |
|
Tymlos |
C9399 |
|
J3490 |
||
ING-CC-0042 |
Siliq |
C9399 |
J3490 |
||
J3590 |
||
Taltz |
C9399 |
|
J3490 |
||
J3590 |
||
ING-CC-0048 |
Spinraza |
J2326 |
ING-CC-0062 |
Avsola |
Q5121 |
Erelzi |
J3590 |
|
Eticovo |
J3590 |
|
ING-CC-0066 |
Kevzara |
C9399 |
J3590 |
||
J3490 |
||
ING-CC-0075 |
Riabni |
Q5123 |
ING-CC-0077 |
Palynziq |
C9399 |
J3590 |
||
ING-CC-0082 |
Onpattro |
J0222 |
ING-CC-0156 |
Reblozyl |
J0896 |
ING-CC-0159 |
Scenesse |
J7352 |
ING-CC-0160 |
Vyepti |
J3032 |
ING-CC-0162 |
Tepezza |
J3241 |
ING-CC-0163 |
Durysta |
J7351 |
ING-CC-0170 |
Uplizna |
J1823 |
ING-CC-0172 |
Viltepso |
J1427 |
ING-CC-0173 |
Enspryng |
J3490 |
J3590 |
||
ING-CC-0174 |
Kesimpta |
C9399 |
J3490 |
||
J3590 |
||
ING-CC-0177 |
Zilretta |
J3304 |
ING-CC-0181 |
Veklury |
J3490 |
ING-CC-0183 |
Sogroya |
J3590 |
ING-CC-0185 |
Oxlumo |
J0224 |
ING-CC-0188 |
Imcivree |
J3490 |
J3590 |
||
ING-CC-0193 |
Evkeeza |
J3490 |
C9079 |
||
ING-CC-0194 |
Cabenuva |
J3490 |
C9077 |
PUBLICATIONS: October 2021 Anthem Provider News - Virginia
To view this article online:
Visit https://providernews.anthem.com/virginia/articles/specialty-pharmacy-updates-are-available-8871
Or scan this QR code with your phone